Life SciencesLiability
Get a quote

TL;DR

New York City is one of the largest US digital health and health-technology hubs, spanning telehealth and virtual-care platforms, digital therapeutics, health-data and analytics companies, and consumer health apps. For these software-first businesses, cyber and technology errors-and-omissions coverage become the primary liability vehicles, layered with HIPAA business-associate exposure, SaMD device structure where applicable, and the New York SHIELD Act. Traditional products liability alone is structurally inadequate.

New York City digital health

Digital Health Insurance in New York City

New York City anchors one of the largest digital health and health-technology ecosystems in the United States. The concentration runs from health-insurance technology and virtual-care platforms to digital therapeutics, health-data and analytics companies, and consumer health applications, clustered across Manhattan and the broader metro. This ecosystem is distinct from the city's academic biotech cluster, and its risk profile is driven by software, data, and clinical decision-making rather than physical product manufacturing.

For a digital health company, the product is code, and the exposures follow the software rather than a tangible good. A liability program built only around traditional products coverage leaves the real risks uninsured, because the loss events are data breaches, algorithm errors, service failures, and regulatory action tied to health information. The coverage architecture below reflects how A-rated specialty markets structure programs for New York City digital health companies.

Get a quoteRun the Free Analyzer

Last updated 2026-07-13

Cluster shape

The New York City digital health cluster

The NYC digital health cluster is broad and software-defined. It includes health-insurance technology companies, telehealth and virtual-care platforms, digital therapeutics developers, health-data and analytics firms, and consumer-facing health apps, most of them concentrated in Manhattan and the surrounding metro. These businesses sit at the intersection of technology, healthcare delivery, and regulated health data.

What ties the cluster together from an underwriting standpoint is that software is the product and health data is the raw material. A telehealth platform, a digital therapeutic, and a health-analytics vendor may look different commercially, but each carries the same core exposures: sensitive protected health information, dependence on cloud and third-party infrastructure, and potential clinical consequences when the software misbehaves.

This page addresses that software-first population specifically. It is deliberately separate from New York City's academic and laboratory biotech cluster, which has its own coverage page, because the underwriting questions, primary products, and regulatory drivers for digital health differ materially from those for wet-lab research and biologics development.

Coverage architecture

How digital health coverage is structured

For digital health companies, cyber and technology errors-and-omissions (Tech E&O) become the primary liability vehicles because the software is the product. Cyber responds to data breaches, ransomware, and privacy events across large volumes of protected health information, while Tech E&O responds to financial harm caused by software errors, service failures, and unmet performance obligations. These two products, often written together, carry the exposure that a traditional products-liability policy is not designed to reach.

Where a company's software qualifies as software as a medical device (SaMD), the program needs SaMD-specific structure, because the software is then a regulated device and can carry bodily-injury as well as economic exposure. Algorithm and AI decision-support liability is a related concern: when software influences diagnosis, triage, or treatment decisions, an erroneous output can translate into patient harm, and the program must contemplate that pathway. Market-typical limits for these placements commonly range from roughly $10M-$50M depending on data volume, clinical role, and contractual requirements.

HIPAA business-associate scope is the other structural pillar. Digital health vendors typically act as business associates to covered entities such as health plans and providers, which extends direct HIPAA obligations and breach-notification duties to the vendor. Underwriters expect a mature security posture, most commonly evidenced by SOC 2 or a comparable attestation, and they price and structure the program around it. A well-built stack coordinates cyber, Tech E&O, and, where relevant, SaMD device coverage so that a single incident does not fall between policies.

Regulatory + market context

New York regulatory environment

New York layers a state data-security regime on top of federal HIPAA. The New York SHIELD Act imposes data-security and breach-notification requirements on any business holding the private information of New York residents, adding a state layer above HIPAA that applies regardless of whether an entity is HIPAA-covered. For digital health companies handling large volumes of New York resident data, this creates overlapping obligations that a cyber and privacy program must be built to satisfy.

Underwriter security expectations move in step with this regulatory posture. Specialty carriers writing New York City digital health risks generally expect SOC 2 or comparable security attestation, documented breach-response capability, and evidence of controls sufficient to meet both HIPAA and SHIELD Act standards. The strength of that security posture directly shapes available limits, retentions, and pricing, making security maturity a core underwriting variable rather than a formality.

Frequently asked

Common questions from New York City digital health operators

Why are cyber and Tech E&O the primary coverages for a digital health company?

Because the software is the product. In digital health, losses arise from data breaches, software errors, and service failures rather than a defective physical good, so cyber and technology errors-and-omissions become the vehicles that actually respond. Cyber addresses privacy events and breaches across protected health information, while Tech E&O addresses financial harm from software errors and unmet performance obligations. A traditional products-liability policy alone is structurally inadequate for these exposures.

What does HIPAA business-associate scope mean for our program?

Digital health vendors typically serve health plans and providers as business associates, which extends direct HIPAA obligations, including safeguards and breach-notification duties, to the vendor itself. That status increases both the regulatory and contractual exposure your program has to cover, and it is usually reflected in business-associate agreements that impose specific security and indemnity requirements. Underwriters review these relationships closely, and the cyber and privacy coverage is structured to align with the HIPAA duties you take on.

When is our product considered software as a medical device (SaMD)?

Software is generally treated as software as a medical device when it is intended for a medical purpose such as diagnosis, treatment, or clinical decision-making, on its own rather than as a component of a hardware device. When your software meets that threshold it is a regulated device, and the liability program needs SaMD-specific structure that can respond to bodily-injury as well as economic exposure. Algorithm and AI decision-support functions raise the same question, because software that influences clinical decisions can carry patient-harm liability.

How do the NY SHIELD Act and underwriter security expectations affect the program?

The New York SHIELD Act adds a state data-security and breach-notification layer above HIPAA for any business holding the private information of New York residents, creating overlapping obligations for NYC digital health companies. Specialty carriers respond by expecting a mature security posture, most commonly SOC 2 or a comparable attestation, before offering competitive terms. That security maturity directly affects available limits, retentions, and pricing, so demonstrating strong controls is central to structuring the program.

Telehealth & digital health practice →Digital health startup insurance →NYC biotech insurance →New York state guide →

Free coverage review

A specialist will reach out by end of business day.

Programs placed through A-rated specialty markets. Send your contract, insurance schedule, or current COI - a specialist returns a clause-by-clause read by end of business day.

Get my quote

Specifically for New York City digital health operators.

Programs placed through A-rated specialty markets. Your specialist handles unlimited certificates of insurance, annual coverage reviews, and claims advocacy.